This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Membranoproliferative-glomerulonephritis (MPGN) is a kidney disease of unknown etiology which might cause over a variable period of time End State Renal Disease (ESRD). Recent studies have postulated that in MPGN patient there is a production of an autoantibody to the alternative pathway of complement which is called C3 nephritic factor (C3NeF) and it is thought to play a major role in development of MPGN. This study is designed to determine if IGIV can modulate the functional activity of C3NeF as it contains anti-idoitypic antibodies directed against C3NeF.
Showing the most recent 10 out of 370 publications